1. A benzamide-linked small molecule HS-Cf inhibits TNF-α-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics.
- Author
-
Liu FC, Huang HS, Huang CY, Yang R, Chang DM, Lai JH, and Ho LJ
- Subjects
- Animals, Benzamides chemistry, Cells, Cultured, Chondrocytes immunology, Chondrocytes metabolism, Chondrocytes pathology, Collagen Type II genetics, Collagen Type II metabolism, Disease Models, Animal, Endopeptidases genetics, Endopeptidases metabolism, Gene Expression Regulation drug effects, Gene Expression Regulation immunology, Humans, Interferon Regulatory Factor-1 genetics, Interferon Regulatory Factor-1 immunology, Interferon Regulatory Factor-1 metabolism, Nitric Oxide Synthase Type II genetics, Nitric Oxide Synthase Type II metabolism, Osteoarthritis immunology, Osteoarthritis pathology, Signal Transduction drug effects, Small Molecule Libraries, Swine, Tumor Necrosis Factor-alpha immunology, Tumor Necrosis Factor-alpha metabolism, Benzamides pharmacology, Chondrocytes drug effects, Immunosuppressive Agents pharmacology, Joints pathology, Osteoarthritis drug therapy
- Abstract
Background: Using tumor necrosis factor-alpha (TNF-α)-activated porcine chondrocytes as a screening tool, we aim to synthesize and identify small-molecule inhibitors preserving immunomodulatory effects as therapeutics for osteoarthritis (OA)., Methods: Chondrocytes were isolated from pig joints. A minilibrary of 300 benzamide-linked small molecules was established. The levels of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) were measured by Western blot and Griess reaction, respectively. Proteoglycan degradation in cartilage explants was determined by histochemistry analysis. The activation of transcription factors and protein kinases was determined by electrophoretic mobility shift assays or Western blots. Zymography and real-time reverse transcriptase-polymerase chain reaction were used to determine enzyme activity and expression of matrix metalloproteinases (MMPs) and aggrecanases, respectively., Results: Bioassay screening of benzamide-linked small molecules revealed that 2-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide (HS-Cf) was a potent inhibitor of NO production and iNOS expression in TNF-α-stimulated porcine chondrocytes. HS-Cf suppressed TNF-α-induced activity of MMP-13 and expressions of several aggrecanases and prevented TNF-α-mediated reduction of collagen II. Histochemistry analysis confirmed that HS-Cf could prevent TNF-α-induced degradation and release of proteoglycan/aggrecan in cartilage explants. Such effects by HS-Cf were likely through suppressing TNF-α-induced interferon regulatory factor-1 (IRF-1) but not nuclear factor-kappaB signaling. The significance of IRF-1 was further confirmed by short hairpin knockdown studies., Conclusions: In a minilibrary containing 300 small molecules, we identified a benzamide-linked small molecule, HS-Cf, that through down-regulating TNF-α-induced IRF-1 activity suppressed chondrocyte activation and prevented cartilage destruction. HS-Cf might be a potential disease-modifying drug for OA therapeutics.
- Published
- 2011
- Full Text
- View/download PDF